Journey Medical (DERM) vs Veraxa Biotech (VRXA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Journey Medical (DERM) has outperformed Veraxa Biotech (VRXA) over the past year, losing 21.2% versus a loss of 88.5%. Veraxa Biotech is the larger company by market cap ($169.7 million vs $167.9 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | DERM | VRXA |
|---|---|---|
| Share price | $5.95 | $1.20 |
| Market cap | $167.94M | $169.69M |
| 1-day change | -3.41% | +11.11% |
| YTD return | -22.83% | -88.75% |
| 1-year return | -21.19% | -88.53% |
| EPS (TTM) | $-0.21 | $-0.57 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $9.56 | $27.36 |
| 52-week low | $4.31 | $1.04 |
| Distance from 52-week high | -37.73% | -95.61% |
| Average volume | 181.79K | 267.22K |
| Shares outstanding | 22.22M | 141.41M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- DERM has outperformed VRXA by 67.3 percentage points over the past year.
DERM vs VRXA FAQ
Which is bigger, Journey Medical or Veraxa Biotech?
Veraxa Biotech (VRXA) is larger, with a market capitalization of $169.69M compared with $167.94M for Journey Medical (DERM).
Which stock has performed better over the past year, DERM or VRXA?
DERM returned -21.19% over the past 12 months, compared with -88.53% for VRXA (price return, excluding dividends). Past performance does not predict future results.
Are Journey Medical and Veraxa Biotech in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.